Literature DB >> 15007172

Fhit is a physiological target of the protein kinase Src.

Yuri Pekarsky1, Preston N Garrison, Alexey Palamarchuk, Nicola Zanesi, Rami I Aqeilan, Kay Huebner, Larry D Barnes, Carlo M Croce.   

Abstract

The FHIT gene is a tumor suppressor that is frequently inactivated by genomic alterations at chromosomal region 3p14.2. In the last few years, a considerable amount of data describing inactivation of FHIT in a variety of human malignancies and demonstrating the tumor suppressor potential of Fhit have been reported. Despite the demonstration that FHIT functions as a tumor suppressor, the pathway through which Fhit induces apoptosis and inhibits growth of cancer cells is not known. Our data demonstrate that Fhit is a target of tyrosine phosphorylation by the Src protein kinase. We show that Src phosphorylates Y114 of Fhit in vitro and in vivo, providing insight into a biochemical pathway involved in Fhit signaling.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15007172      PMCID: PMC374320          DOI: 10.1073/pnas.0400481101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  23 in total

1.  Effect of adenoviral transduction of the fragile histidine triad gene into esophageal cancer cells.

Authors:  H Ishii; K R Dumon; A Vecchione; F Trapasso; K Mimori; H Alder; M Mori; G Sozzi; R Baffa; K Huebner; C M Croce
Journal:  Cancer Res       Date:  2001-02-15       Impact factor: 12.701

2.  Fragile histidine triad expression delays tumor development and induces apoptosis in human pancreatic cancer.

Authors:  K R Dumon; H Ishii; A Vecchione; F Trapasso; G Baldassarre; F Chakrani; T Druck; E F Rosato; N N Williams; R Baffa; M J During; K Huebner; C M Croce
Journal:  Cancer Res       Date:  2001-06-15       Impact factor: 12.701

3.  The tumor spectrum in FHIT-deficient mice.

Authors:  N Zanesi; V Fidanza; L Y Fong; R Mancini; T Druck; M Valtieri; T Rüdiger; P A McCue; C M Croce; K Huebner
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-21       Impact factor: 11.205

4.  Regulation of both apoptosis and cell survival by the v-Src oncoprotein.

Authors:  D Johnson; M Agochiya; K Samejima; W Earnshaw; M Frame; J Wyke
Journal:  Cell Death Differ       Date:  2000-08       Impact factor: 15.828

5.  Association of FHIT (fragile histidine triad), a candidate tumour suppressor gene, with the ubiquitin-conjugating enzyme hUBC9.

Authors:  Y Shi; M Zou; N R Farid; M C Paterson
Journal:  Biochem J       Date:  2000-12-01       Impact factor: 3.857

6.  Muir-Torre-like syndrome in Fhit-deficient mice.

Authors:  L Y Fong; V Fidanza; N Zanesi; L F Lock; L D Siracusa; R Mancini; Z Siprashvili; M Ottey; S E Martin; T Druck; P A McCue; C M Croce; K Huebner
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-25       Impact factor: 11.205

7.  FHIT loss of function in human primary breast cancer correlates with advanced stage of the disease.

Authors:  M Campiglio; Y Pekarsky; S Menard; E Tagliabue; S Pilotti; C M Croce
Journal:  Cancer Res       Date:  1999-08-15       Impact factor: 12.701

8.  Dexamethasone-induced apoptosis of thymocytes: role of glucocorticoid receptor-associated Src kinase and caspase-8 activation.

Authors:  Maria Cristina Marchetti; Barbara Di Marco; Grazia Cifone; Graziella Migliorati; Carlo Riccardi
Journal:  Blood       Date:  2002-08-29       Impact factor: 22.113

9.  Adenovirus E4 open reading frame 4-induced apoptosis involves dysregulation of Src family kinases.

Authors:  J N Lavoie; C Champagne; M C Gingras; A Robert
Journal:  J Cell Biol       Date:  2000-09-04       Impact factor: 10.539

10.  Src tyrosine kinase augments taxotere-induced apoptosis through enhanced expression and phosphorylation of Bcl-2.

Authors:  V Boudny; S Nakano
Journal:  Br J Cancer       Date:  2002-02-01       Impact factor: 7.640

View more
  19 in total

1.  FHIT-proteasome degradation caused by mitogenic stimulation of the EGF receptor family in cancer cells.

Authors:  Francesca Bianchi; Alessandra Magnifico; Clelia Olgiati; Nicola Zanesi; Yuri Pekarsky; Elda Tagliabue; Carlo Maria Croce; Sylvie Ménard; Manuela Campiglio
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-01       Impact factor: 11.205

2.  Comprehensive characterization of the genomic alterations in human gastric cancer.

Authors:  Juan Cui; Yanbin Yin; Qin Ma; Guoqing Wang; Victor Olman; Yu Zhang; Wen-Chi Chou; Celine S Hong; Chi Zhang; Sha Cao; Xizeng Mao; Ying Li; Steve Qin; Shaying Zhao; Jing Jiang; Phil Hastings; Fan Li; Ying Xu
Journal:  Int J Cancer       Date:  2014-12-03       Impact factor: 7.396

Review 3.  Fhit tumor suppressor: guardian of the preneoplastic genome.

Authors:  Flavia Pichiorri; Tiziana Palumbo; Sung-Suk Suh; Hiroshi Okamura; Francesco Trapasso; Hideshi Ishii; Kay Huebner; Carlo M Croce
Journal:  Future Oncol       Date:  2008-12       Impact factor: 3.404

4.  The tumor suppressor Fhit acts as a repressor of beta-catenin transcriptional activity.

Authors:  Jörg Weiske; Kai Frederik Albring; Otmar Huber
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-10       Impact factor: 11.205

5.  Genome-wide SNP typing reveals signatures of population history.

Authors:  Austin L Hughes; Robert Welch; Vinita Puri; Casey Matthews; Kashif Haque; Stephen J Chanock; Meredith Yeager
Journal:  Genomics       Date:  2008-05-16       Impact factor: 5.736

6.  Correlation of fragile histidine triad (Fhit) protein structural features with effector interactions and biological functions.

Authors:  Flavia Pichiorri; Hiroshi Okumura; Tatsuya Nakamura; Preston N Garrison; Pierluigi Gasparini; Sung-Suk Suh; Teresa Druck; Kelly A McCorkell; Larry D Barnes; Carlo M Croce; Kay Huebner
Journal:  J Biol Chem       Date:  2008-11-12       Impact factor: 5.157

Review 7.  Fragile histidine triad protein: structure, function, and its association with tumorogenesis.

Authors:  Md Imtaiyaz Hassan; Abdullah Naiyer; Faizan Ahmad
Journal:  J Cancer Res Clin Oncol       Date:  2009-12-24       Impact factor: 4.553

8.  Fhit modulation of the Akt-survivin pathway in lung cancer cells: Fhit-tyrosine 114 (Y114) is essential.

Authors:  S Semba; F Trapasso; M Fabbri; K A McCorkell; S Volinia; T Druck; D Iliopoulos; Y Pekarsky; H Ishii; P N Garrison; L D Barnes; C M Croce; K Huebner
Journal:  Oncogene       Date:  2006-05-11       Impact factor: 8.756

9.  Multiple Patterns of FHIT Gene Homozygous Deletion in Egyptian Breast Cancer Patients.

Authors:  Heba M S Ismail; Amina M Medhat; Amr M Karim; Nadia I Zakhary
Journal:  Int J Breast Cancer       Date:  2011-10-19

10.  Activation state-dependent interaction between Gαq subunits and the Fhit tumor suppressor.

Authors:  Hao Zuo; Grace P W Chan; Jing Zhu; Wendy W S Yeung; Anthony S L Chan; Hermann Ammer; Yung H Wong
Journal:  Cell Commun Signal       Date:  2013-08-15       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.